Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Fallopian Tube Neoplasms × saracatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1 Fallopian Tube Neoplasms 1

Interventions

Paclitaxel 5 liposomal doxorubicin 4 Topotecan 3 Doxorubicin 2 Carboplatin 2 Bevacizumab 2 saracatinib 1 pegfilgrastim 1 olaparib 1 cediranib 1 atezolizumab 1 Taxes 1 Poly(ADP-ribose) Polymerase Inhibitors 1 Neoadjuvant Therapy 1 Magnetic Resonance Spectroscopy 1 Immunoglobulin G 1 Ifosfamide 1 Gemcitabine 1 Disulfides 1 Diathermy 1 Chemotherapy, Adjuvant 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01196741 2015-05-05

SaPPrOC

University College, London

Phase 2/3 Completed

107 enrolled 17 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡